Skip to main content
. 2019 Mar 28;20(5):12–20. doi: 10.1002/acm2.12572

Figure 2.

Figure 2

Distribution of the mean dose discrepancies between Mobius3D and Planning Station for (a) the planning target volume at the prostate and the head‐and‐neck and (b) for the organ at risk (OAR) at all treatment sites.